NYXH
Nyxoah SA
Price Chart
Latest Quote
$1.64
+0.06 (+4.14%)
Current Price
| Previous Close | $1.57 |
| Open | $1.53 |
| Day High | $1.64 |
| Day Low | $1.53 |
| Volume | 48,163 |
Stock Information
Note: Financial values converted from EUR to USD
| Shares Outstanding | 99.93M |
| Total Debt | $41.07M |
| Cash Equivalents | $29.52M |
| Revenue | $17.45M |
| Net Income | $-95.21M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $163.38M |
| EPS (TTM) | $-2.45 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $78.70M |
| Sales | $17.45M |
| Income | $-95.21M |
| Book/sh | $0.95 |
| Cash/sh | $0.26 |
| Employees | 153 |
Financial Ratios
| Quick Ratio | 0.85 |
| Current Ratio | 0.99 |
| Debt/Eq | 100.58 |
Returns & Margins
| ROA | -44.59% |
| ROE | -129.97% |
| Gross Margin | 60.71% |
| Operating Margin | -321.72% |
Ownership
| Insider Ownership | 33.61% |
| Institutional Ownership | 12.32% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.35 |
| P/S | 10.66 |
| P/B | 1.72 |
Analyst Data
| Recommendation | buy |
| Target Price | $8.30 |
Technical Indicators
| SMA20 | $2.06 |
| SMA50 | $2.66 |
| SMA200 | $4.16 |
| RSI | 20.53 |
| ATR | 0.2832 |
| Shares Float | 23.64M |
| Short Float | 1.30% |
| Short Ratio | 10.81 |
| Volatility | 0.89 |
| Rel Volume | 0.07 |
Performance History
| Week | +5.48% |
| Month | -43.03% |
| Quarter | -48.26% |
| 6 Months | -64.84% |
| YTD | -63.67% |
| Year | -78.79% |
| 3 Years | -79.56% |
| 5 Years | -93.94% |
| 10 Years | -93.19% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $1.63 | 48,163 |
| 2026-06-22 | $1.57 | 132,500 |
| 2026-06-18 | $1.60 | 281,700 |
| 2026-06-17 | $1.59 | 1,697,600 |
| 2026-06-16 | $1.58 | 453,900 |
| 2026-06-15 | $1.55 | 623,500 |
| 2026-06-12 | $1.39 | 1,065,700 |
| 2026-06-11 | $1.49 | 684,300 |
| 2026-06-10 | $1.31 | 1,646,400 |
| 2026-06-09 | $1.34 | 971,800 |
| 2026-06-08 | $1.39 | 3,701,500 |
| 2026-06-05 | $1.45 | 2,469,600 |
| 2026-06-04 | $2.88 | 41,100 |
| 2026-06-03 | $2.87 | 18,700 |
| 2026-06-02 | $2.97 | 39,100 |
| 2026-06-01 | $3.02 | 6,100 |
| 2026-05-29 | $2.98 | 15,400 |
| 2026-05-28 | $2.99 | 16,900 |
| 2026-05-27 | $2.82 | 21,700 |
| 2026-05-26 | $2.70 | 39,700 |
About Nyxoah SA
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
đ° Latest News
Why Is NYXH Stock Falling Today?
Stocktwits âĸ 2026-06-05T16:58:40ZNyxoah SA (NYXH) Q1 2026 Earnings Call Highlights: Strong U.S. ...
GuruFocus.com âĸ 2026-05-13T05:01:47ZNyxoah Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-13T01:09:09ZNyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-12T23:00:03ZNyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks âĸ 2026-05-05T14:00:06ZHow The Nyxoah (ENXTBR:NYXH) Narrative Is Shifting With CMS Codes And Trimmed Targets
Simply Wall St. âĸ 2026-05-05T03:18:09ZBaird Lowers its Price Target on Nyxoah SA (NYXH) to $4.62 from $5.87
Insider Monkey âĸ 2026-04-04T12:16:30ZNyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026
MarketBeat âĸ 2026-03-21T12:07:03ZNyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges
GuruFocus.com âĸ 2026-03-20T05:00:34ZNyxoah (NYXH) Q4 2025 Earnings Call Transcript
Motley Fool âĸ 2026-03-19T23:43:56Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $610,425 | $134,888 | $386,374 | $150,892 |
| Cost Of Revenue | $4,222,679 | $1,774,120 | $1,893,004 | $1,314,586 |
| Total Revenue | $11,454,046 | $5,168,038 | $4,970,279 | $3,525,377 |
| Operating Revenue | $11,454,046 | $5,168,038 | $4,970,279 | $3,525,377 |
| Expenses | ||||
| Interest Expense | $1,933,013 | $1,012,803 | $248,057 | $270,919 |
| Total Expenses | $106,266,573 | $72,393,688 | $56,527,205 | $40,675,582 |
| Rent Expense Supplemental | $563,557 | $730,453 | $362,369 | $502,972 |
| Other Income Expense | $-2,193,644 | $2,032,465 | $-1,057,385 | $3,296,753 |
| Net Non Operating Interest Income Expense | $-4,821,673 | $684,728 | $1,566,072 | $-504,115 |
| Total Other Finance Cost | $4,985,139 | $1,162,551 | $1,124,829 | $658,436 |
| Interest Expense Non Operating | $1,933,013 | $1,012,803 | $248,057 | $270,919 |
| Operating Expense | $102,043,893 | $70,619,569 | $54,634,201 | $39,360,996 |
| Other Operating Expenses | $-1,505,487 | $-1,152,263 | $-621,856 | $-323,503 |
| General And Administrative Expense | $53,082,989 | $31,066,529 | $23,599,679 | $20,508,687 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-102,977,821 | $-67,713,762 | $-49,396,432 | $-35,693,872 |
| Net Interest Income | $-4,821,673 | $684,728 | $1,566,072 | $-504,115 |
| Interest Income | $2,096,479 | $2,860,082 | $2,938,957 | $425,240 |
| Normalized Income | $-101,332,588 | $-69,238,110 | $-48,373,262 | $-38,166,437 |
| Net Income From Continuing And Discontinued Operation | $-102,977,821 | $-67,713,762 | $-49,396,432 | $-35,693,872 |
| Total Operating Income As Reported | $-95,433,240 | $-67,225,650 | $-51,556,926 | $-37,150,205 |
| Net Income Common Stockholders | $-102,977,821 | $-67,713,762 | $-49,396,432 | $-35,693,872 |
| Net Income | $-102,977,821 | $-67,713,762 | $-49,396,432 | $-35,693,872 |
| Net Income Including Noncontrolling Interests | $-102,977,821 | $-67,713,762 | $-49,396,432 | $-35,693,872 |
| Net Income Continuous Operations | $-102,977,821 | $-67,713,762 | $-49,396,432 | $-35,693,872 |
| Pretax Income | $-101,824,415 | $-64,508,458 | $-51,048,238 | $-34,357,567 |
| Special Income Charges | $-624,143 | $0 | $0 | - |
| Interest Income Non Operating | $2,096,479 | $2,860,082 | $2,938,957 | $425,240 |
| Operating Income | $-94,812,526 | $-67,225,650 | $-51,556,926 | $-37,150,205 |
| Depreciation Amortization Depletion Income Statement | $1,513,489 | $1,467,764 | $1,191,129 | $1,044,810 |
| Depreciation And Amortization In Income Statement | $1,513,489 | $1,467,764 | $1,191,129 | $1,044,810 |
| Gross Profit | $7,231,367 | $3,393,919 | $3,077,275 | $2,210,791 |
| Per Share | ||||
| Diluted EPS | $-2.70 | $-2.07 | $-1.77 | $-1.38 |
| Basic EPS | $-2.70 | $-2.07 | $-1.77 | $-1.38 |
| Other | ||||
| Tax Effect Of Unusual Items | $-548,411 | $508,116 | $-34,215 | $824,188 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-92,572,014 | $-62,421,123 | $-47,045,038 | $-35,174,896 |
| Total Unusual Items | $-2,193,644 | $2,032,465 | $-1,057,385 | $3,296,753 |
| Total Unusual Items Excluding Goodwill | $-2,193,644 | $2,032,465 | $-1,057,385 | $3,296,753 |
| Reconciled Depreciation | $5,125,743 | $3,106,996 | $2,697,759 | $2,208,505 |
| EBITDA (Bullshit earnings) | $-94,765,658 | $-60,388,659 | $-48,102,422 | $-31,878,143 |
| EBIT | $-99,891,401 | $-63,495,655 | $-50,800,182 | $-34,086,648 |
| Diluted Average Shares | $43,560,838 | $37,431,598 | $31,970,898 | $29,523,468 |
| Basic Average Shares | $43,560,838 | $37,431,598 | $31,970,898 | $29,523,468 |
| Diluted NI Availto Com Stockholders | $-102,977,821 | $-67,713,762 | $-49,396,432 | $-35,693,872 |
| Tax Provision | $1,153,406 | $3,205,304 | $-1,651,806 | $1,336,305 |
| Gain On Sale Of Ppe | $-185,185 | $0 | $0 | - |
| Other Special Charges | $-136,031 | - | - | - |
| Write Off | $574,989 | $0 | $0 | - |
| Gain On Sale Of Security | $-1,569,502 | $2,032,465 | $-1,057,385 | $3,296,753 |
| Research And Development | $48,952,902 | $39,237,539 | $30,465,248 | $18,131,001 |
| Selling General And Administration | $53,082,989 | $31,066,529 | $23,599,679 | $20,508,687 |
| Other Gand A | $21,915,866 | $16,713,534 | $11,886,145 | $9,077,503 |
| Insurance And Claims | $492,684 | $584,134 | $1,125,972 | $1,719,250 |
| Rent And Landing Fees | $563,557 | $730,453 | $362,369 | $502,972 |
| Salaries And Wages | $30,110,882 | $13,038,408 | $10,225,194 | $9,208,962 |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,119,113 | $71,871,283 | $58,772,289 | $91,851,850 |
| Total Assets | $135,426,380 | $181,076,813 | $141,926,151 | $166,976,448 |
| Total Non Current Assets | $65,452,673 | $68,956,331 | $63,792,865 | $52,367,397 |
| Non Current Deferred Assets | $99,451 | $86,877 | $64,015 | $53,727 |
| Non Current Deferred Taxes Assets | $99,451 | $86,877 | $64,015 | $53,727 |
| Non Current Accounts Receivable | $1,859,854 | $1,720,393 | $1,332,876 | $197,759 |
| Financial Assets | $104,024 | $128,029 | - | - |
| Goodwill And Other Intangible Assets | $57,279,377 | $57,591,448 | $53,278,462 | $45,692,729 |
| Other Intangible Assets | $57,279,377 | $57,591,448 | $53,278,462 | $45,692,729 |
| Current Assets | $69,973,707 | $112,120,482 | $78,133,286 | $114,609,051 |
| Hedging Assets Current | $4,572 | $0 | $392,090 | $1,143 |
| Current Deferred Assets | $757,887 | $1,049,383 | - | - |
| Prepaid Assets | $350,937 | $839,049 | - | - |
| Inventory | $5,326,932 | $5,390,946 | $3,789,437 | $1,008,230 |
| Receivables | $8,662,551 | $7,041,609 | $6,432,327 | $3,700,274 |
| Other Receivables | $1,027,663 | $1,223,137 | $1,384,316 | $877,915 |
| Taxes Receivable | $1,628,944 | $1,952,446 | $1,895,290 | $1,149,977 |
| Accounts Receivable | $6,005,944 | $3,866,026 | $3,152,721 | $1,672,382 |
| Cash Cash Equivalents And Short Term Investments | $54,870,826 | $97,799,495 | $66,012,801 | $108,431,639 |
| Cash And Cash Equivalents | $34,294,695 | $39,078,646 | $24,702,789 | $20,448,102 |
| Cash Equivalents | $25,298,353 | $32,258,801 | $10,468,678 | $41,152 |
| Cash Financial | $8,996,342 | $6,819,844 | $14,234,110 | $20,406,950 |
| Other Current Assets | - | $1,893,004 | $1,506,630 | $1,467,764 |
| Debt | ||||
| Net Debt | $10,354,366 | - | - | - |
| Total Debt | $46,267,717 | $25,895,061 | $14,522,176 | $13,583,676 |
| Long Term Debt And Capital Lease Obligation | $19,096,936 | $24,333,561 | $13,133,287 | $12,317,101 |
| Long Term Debt | $18,368,770 | $21,404,892 | $9,571,330 | $9,360,997 |
| Current Debt And Capital Lease Obligation | $27,170,781 | $1,561,500 | $1,388,889 | $1,266,575 |
| Current Debt | $26,280,292 | $283,493 | $416,095 | $444,673 |
| Other Current Borrowings | $26,280,292 | $283,493 | $416,095 | $444,673 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $79,266,116 | $51,614,082 | $29,875,399 | $29,431,869 |
| Total Non Current Liabilities Net Minority Interest | $23,301,325 | $27,003,886 | $13,365,340 | $12,384,545 |
| Derivative Product Liabilities | $1,830,133 | - | - | - |
| Non Current Deferred Liabilities | $778,464 | $561,271 | $10,288 | $0 |
| Non Current Deferred Taxes Liabilities | $0 | $21,719 | $10,288 | $0 |
| Current Liabilities | $55,964,791 | $24,610,196 | $16,510,059 | $17,047,325 |
| Other Current Liabilities | $1,724,966 | $1,664,380 | $331,504 | $10,288 |
| Current Deferred Liabilities | $1,021,948 | $133,745 | $0 | - |
| Payables And Accrued Expenses | $25,416,095 | $20,218,335 | $13,885,459 | $15,070,873 |
| Payables | $10,691,586 | $9,220,393 | $6,961,591 | $6,467,764 |
| Total Tax Payable | $4,783,951 | $4,934,842 | $2,272,519 | $4,176,955 |
| Accounts Payable | $5,907,636 | $4,285,551 | $4,689,072 | $2,141,061 |
| Other Non Current Liabilities | - | $965,935 | - | $1,143 |
| Other Payable | - | - | $228,624 | $149,749 |
| Equity | ||||
| Common Stock Equity | $56,160,264 | $129,462,731 | $112,050,752 | $137,544,578 |
| Total Equity Gross Minority Interest | $56,160,264 | $129,462,731 | $112,050,752 | $137,544,578 |
| Stockholders Equity | $56,160,264 | $129,462,731 | $112,050,752 | $137,544,578 |
| Other Equity Interest | $14,168,953 | $10,631,001 | $8,757,430 | $6,452,903 |
| Gains Losses Not Affecting Retained Earnings | $1,284,865 | $1,044,810 | $156,607 | $201,189 |
| Other Equity Adjustments | $1,284,865 | $1,044,810 | $156,607 | $201,189 |
| Retained Earnings | $-349,827,381 | $-248,896,885 | $-183,846,589 | $-135,130,312 |
| Other | ||||
| Ordinary Shares Number | $49,184,338 | $42,783,795 | $32,777,760 | $29,545,357 |
| Share Issued | $49,184,338 | $42,783,795 | $32,777,760 | $29,545,357 |
| Tangible Book Value | $-1,119,113 | $71,871,283 | $58,772,289 | $91,851,850 |
| Invested Capital | $100,809,325 | $151,151,117 | $122,038,177 | $147,350,248 |
| Working Capital | $14,008,916 | $87,510,286 | $61,623,227 | $97,561,726 |
| Capital Lease Obligations | $1,618,656 | $4,206,676 | $4,534,751 | $3,778,006 |
| Total Capitalization | $74,529,033 | $150,867,623 | $121,622,082 | $146,905,575 |
| Additional Paid In Capital | $383,097,842 | $359,333,553 | $281,352,302 | $260,945,353 |
| Capital Stock | $7,435,985 | $7,350,251 | $5,631,001 | $5,075,446 |
| Common Stock | $7,435,985 | $7,350,251 | $5,631,001 | $5,075,446 |
| Non Current Deferred Revenue | $778,464 | $539,552 | $0 | - |
| Long Term Capital Lease Obligation | $728,166 | $2,928,669 | $3,561,957 | $2,956,104 |
| Long Term Provisions | $1,595,793 | $1,143,118 | $211,477 | $67,444 |
| Current Deferred Revenue | $1,021,948 | $133,745 | $0 | - |
| Current Capital Lease Obligation | $890,489 | $1,278,006 | $972,794 | $821,902 |
| Pensionand Other Post Retirement Benefit Plans Current | $631,001 | $1,032,236 | $904,207 | $699,588 |
| Current Accrued Expenses | $14,724,508 | $10,997,942 | $6,923,868 | $8,603,109 |
| Net PPE | $6,109,968 | $9,429,584 | $9,117,512 | $6,423,182 |
| Accumulated Depreciation | $-5,648,148 | $-6,503,201 | $-4,644,490 | $-3,161,865 |
| Gross PPE | $11,758,116 | $15,932,784 | $13,762,002 | $9,585,048 |
| Leases | $4,705,075 | $2,098,765 | $1,502,058 | $804,755 |
| Construction In Progress | $34,294 | $2,582,304 | $2,349,108 | $820,759 |
| Other Properties | $2,039,323 | $2,174,211 | $1,715,821 | $1,428,898 |
| Machinery Furniture Equipment | $3,036,122 | $3,295,610 | $2,932,099 | $2,387,974 |
| Buildings And Improvements | $1,943,301 | $5,781,893 | $5,262,917 | $4,142,661 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,707,819 | $1,245,999 | $521,262 | $324,646 |
| Work In Process | $2,115,912 | $2,910,379 | $1,748,971 | $114,312 |
| Raw Materials | $1,503,201 | $1,234,568 | $1,519,204 | $569,273 |
| Other Short Term Investments | $20,576,131 | $58,720,849 | $41,310,013 | $87,983,537 |
| Employee Benefits | - | $0 | $10,288 | $0 |
| Non Current Pension And Other Postretirement Benefit Plans | - | $0 | $10,288 | $0 |
| Preferred Stock | - | - | - | $0 |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-83,159,577 | $-63,212,161 | $-63,717,420 | $-51,560,355 |
| Operating Activities | ||||
| Operating Cash Flow | $-78,851,164 | $-56,271,146 | $-51,186,556 | $-32,871,513 |
| Cash Flow From Continuing Operating Activities | $-78,851,164 | $-56,271,146 | $-51,186,556 | $-32,871,513 |
| Operating Gains Losses | $1,754,687 | $-2,032,465 | $1,057,385 | $-3,296,753 |
| Investing Activities | ||||
| Capital Expenditure | $-4,308,413 | $-6,941,015 | $-12,530,864 | $-18,688,843 |
| Investing Cash Flow | $32,386,831 | $-18,661,408 | $36,592,363 | $-102,818,928 |
| Cash Flow From Continuing Investing Activities | $32,386,831 | $-18,661,408 | $36,592,363 | $-102,818,928 |
| Capital Expenditure Reported | $-3,388,203 | $-5,609,282 | $-9,673,068 | $-17,676,040 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $23,850,022 | $79,700,501 | $20,961,362 | $291,495 |
| Financing Cash Flow | $43,560,813 | $88,521,946 | $19,270,690 | $-1,123,685 |
| Cash Flow From Continuing Financing Activities | $43,560,813 | $88,521,946 | $19,270,690 | $-1,123,685 |
| Net Other Financing Charges | $-3,716,278 | $-299,497 | $-58,299 | $-42,295 |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Net Common Stock Issuance | $23,850,022 | $79,700,501 | $20,961,362 | $291,495 |
| Common Stock Issuance | $23,850,022 | $79,700,501 | $20,961,362 | $291,495 |
| Other | ||||
| Repayment Of Debt | $-1,499,771 | $-1,743,256 | $-1,412,894 | $-1,224,280 |
| Issuance Of Debt | $25,720,164 | $11,431,184 | $0 | $0 |
| End Cash Position | $34,294,695 | $39,078,646 | $24,702,789 | $20,448,102 |
| Beginning Cash Position | $39,078,646 | $24,702,789 | $20,448,102 | $154,902,831 |
| Effect Of Exchange Rate Changes | $-1,880,430 | $786,465 | $-421,811 | $2,359,396 |
| Changes In Cash | $-2,903,521 | $13,589,392 | $4,676,497 | $-136,814,126 |
| Interest Paid Cff | $-793,324 | $-566,987 | $-219,479 | $-148,605 |
| Net Issuance Payments Of Debt | $24,220,393 | $9,687,928 | $-1,412,894 | $-1,224,280 |
| Net Long Term Debt Issuance | $24,220,393 | $9,687,928 | $-1,412,894 | $-1,224,280 |
| Long Term Debt Payments | $-1,499,771 | $-1,743,256 | $-1,412,894 | $-1,224,280 |
| Long Term Debt Issuance | $25,720,164 | $11,431,184 | $0 | $0 |
| Interest Received Cfi | $2,459,991 | $2,582,304 | $2,640,604 | $125,743 |
| Net Investment Purchase And Sale | $34,231,824 | $-14,310,699 | $46,482,623 | $-84,255,828 |
| Sale Of Investment | $82,299,952 | $97,521,717 | $137,952,672 | $33,050,982 |
| Purchase Of Investment | $-48,068,129 | $-111,832,416 | $-91,470,048 | $-117,306,810 |
| Net PPE Purchase And Sale | $-916,781 | $-1,323,731 | $-2,857,796 | $-1,012,803 |
| Sale Of PPE | $3,429 | $8,002 | $0 | $0 |
| Purchase Of PPE | $-920,210 | $-1,331,733 | $-2,857,796 | $-1,012,803 |
| Taxes Refund Paid | $-1,192,272 | $-611,568 | $-901,920 | $-468,679 |
| Change In Working Capital | $6,139,689 | $3,385,917 | $-3,994,056 | $98,308 |
| Change In Payables And Accrued Expense | $8,521,948 | $5,845,907 | $547,554 | $703,018 |
| Change In Payable | $8,521,948 | $5,845,907 | $547,554 | $703,018 |
| Change In Inventory | $64,015 | $-1,601,509 | $-2,781,207 | $-612,711 |
| Change In Receivables | $-2,446,273 | $-858,482 | $-1,760,402 | $8,002 |
| Other Non Cash Items | $3,150,434 | $-1,081,390 | $-2,229,081 | $-185,185 |
| Stock Based Compensation | $5,585,277 | $4,535,894 | $2,984,682 | $3,084,133 |
| Unrealized Gain Loss On Investment Securities | $58,299 | $0 | $0 | - |
| Provisionand Write Offof Assets | $430,956 | $933,928 | $246,914 | $42,295 |
| Asset Impairment Charge | $1,920,439 | $0 | $0 | - |
| Depreciation Amortization Depletion | $5,125,743 | $3,106,996 | $2,697,759 | $2,208,505 |
| Depreciation And Amortization | $5,125,743 | $3,106,996 | $2,697,759 | $2,208,505 |
| Amortization Cash Flow | $2,549,154 | $1,104,252 | $1,099,680 | $929,355 |
| Amortization Of Intangibles | $2,549,154 | $1,104,252 | $1,099,680 | $929,355 |
| Depreciation | $2,576,589 | $2,002,743 | $1,598,080 | $1,279,149 |
| Gain Loss On Investment Securities | $-1,812,986 | $460,677 | $-289,209 | $3,109,282 |
| Net Foreign Currency Exchange Gain Loss | $3,382,487 | $-2,493,141 | $1,346,593 | $-6,406,036 |
| Gain Loss On Sale Of PPE | $185,185 | $0 | $0 | - |
| Net Income From Continuing Operations | $-101,824,415 | $-64,508,458 | $-51,048,238 | $-34,357,567 |
| Interest Received Cfo | - | $0 | $0 | $3,429 |
Fetched: 2026-06-23